Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Small Volume Parenterals (SVP): Regulatory, Chemistry and Toxicology Considerations Scenario Large US-based pharma/biotech company, by the name of “Megavac Bio” has marketed a vaccine, “Prevent” since 1980 in the US, Europe, and Asia. Initially the largest markets were the US and Europe but now Asia is the fastest growing market and currently over 70% of units of Prevent are sold in Asia. Because of the market shift and increasing domestic production costs, Megavac is going to close production in the US and shift production to a contractor based in Asia. The drug formulation will remain the same as well as the production process but the primary packaging components will be changed. The current package is a 3mL glass vial (13mm finish) and a 13mm rubber closure that is a blend of chlorobutyl and natural rubber. The new CCS will be a 3mL COC vial (13mm finish) and a 13mm bromobutyl rubber stopper. Both the COC vial and rubber stopper will be made in Asia. The change to COC is being made to reduce breakage during handling and to reduce the weight of the package. The rubber is being changed because the current rubber formulation will not meet current pharmacopoeial and extractables/leachables standards. What packaging concerns should addressed by Megavac in making these changes? 1. Supply chain issues such as… a. Packaging material quality and variability b. Supplier contracts and Change Control issues c. Finished component (vial & stopper) quality and variability including composition and dimensional issues 2. Vaccine DP – CCS compatibility issues such as… a. Particulates b. Extractables/Leachables…chemical & toxicity issues. Rubber ingredients such as metal contaminates, NR latex, PNAs from carbon black, and sensitizers. c. Water vapor and oxygen transmission through COC vial (not an issue with previous glass vial). SVP_Scenario.docx Page 1 d. Migration of label adhesives/inks and other label materials through COC vials into DP (not an issue with previous glass vial). e. Migration of wooden pallet fungicide byproducts, such as 2,4,6tribromoanisole, into COC and rubber polymers. SVP_Scenario.docx Page 2